Circulating plasma galectin-3 predicts new-onset atrial fibrillation in patients after acute myocardial infarction during hospitalization
Abstract Background New-onset atrial fibrillation (NOAF) is a common complication in patients with acute myocardial infarction (AMI) during hospitalization. Galectin-3 (Gal-3) is a novel inflammation marker that is significantly associated with AF. The association between post-AMI NOAF and Gal-3 dur...
Main Authors: | Qianhui Wang, Wei Huai, Xiaoguang Ye, Yuxia Pan, Xinchun Yang, Mulei Chen, Qing-Bian Ma, Yuanfeng Gao, Yuan Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-09-01
|
Series: | BMC Cardiovascular Disorders |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12872-022-02827-y |
Similar Items
-
New-Onset Atrial Fibrillation in Acute Myocardial Infarction Is a Different Phenomenon than Other Pre-Existing Types of That Arrhythmia
by: Monika Raczkowska-Golanko, et al.
Published: (2022-07-01) -
Comprehensive Use of Routine Clinical Parameters to Identify Patients at Risk of New-Onset Atrial Fibrillation in Acute Myocardial Infarction
by: Monika Raczkowska-Golanko, et al.
Published: (2021-08-01) -
Oral anticoagulant therapy for patients with new-onset atrial fibrillation following acute myocardial infarction: A narrative review
by: Shenglong Yu, et al.
Published: (2022-11-01) -
Laboratory biomarker galectin-3 in the diagnostics of myocardial inflammatory changes in patients with atrial fibrillation
by: A. M. Gusakova, et al.
Published: (2023-06-01) -
Gender Differences in the Impact of New-Onset Atrial Fibrillation on Long-Term Risk of Ischemic Stroke after Acute Myocardial Infarction
by: Jeong-Eun Yi, et al.
Published: (2021-11-01)